A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 98
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : AQP4-Ab
Long Form : aquaporin-4 antibody
No. Year Title Co-occurring Abbreviation
2021 Clinical and Prognostic Analysis of Autoantibody-Associated CNS Demyelinating Disorders in Children in Southwest China. ADS, IQR, MOG-Ab
2021 Clinical Characteristics of Chinese Male Patients with Aquaporin-4 Antibody-Positive Late-Onset Neuromyelitis Optica Spectrum Disorder. EDSS, EONMOSD, LONMOSD, MRI, TM
2021 Comparison of clinical characteristics and prognoses in patients with different AQP4-Ab and MOG-Ab serostatus with neuromyelitis optica spectrum disorders. EDSS, MOG-Ab, NMOSD
2021 Current understanding of the epidemiologic and clinical characteristics of optic neuritis. MOG-Ab
2021 Efficacy of Low-Dose Rituximab on Neuromyelitis Optica-Associated Optic Neuritis. AEs, EDSS, ELISA, NMO-ON, RTX
2021 Foveal changes in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive. HCs, NMOSD, ON
2021 Intravenous immunoglobulin as the rescue treatment in NMOSD patients. EDSS, IVIG, IVMT, NMOSD
2021 Neuromyelitis optica spectrum disorder as a paraneoplastic syndrome: a rare and challenging diagnosis. NMOSD
2021 Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies. HCs, MOGAD, NMOSD, RRMS, sGFAP, sNfL
10  2021 What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM). CBA, MOG-Ab, MS, NMOSD
11  2020 Cerebrospinal fluid lactate level in aquaporin-4 antibody positive neuromyelitis optica spectrum disorders: a hint on differential diagnosis and possible immunopathogenesis. AUC, CSF, MS, NMOSD, ROC
12  2020 Different clinical characteristics of longitudinally extensive transverse myelitis with and without connective tissue disorders: a single-center retrospective study. CTD, LETM, SS
13  2020 Differentiate aquaporin-4 antibody negative neuromyelitis optica spectrum disorders from multiple sclerosis by multimodal advanced MRI techniques. FCS, MS, NMOSD
14  2020 Elevated serum interleukin-39 levels in patients with neuromyelitis optica spectrum disorders correlated with disease severity. CNS, EDSS, ELISA, HCs, IL, NMOSD, NND, RRMS
15  2020 Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder. LETM, MOG-AD, MS, NMOSD
16  2020 Myelitis in inflammatory disorders associated with myelin oligodendrocyte glycoprotein antibody and aquaporin-4 antibody: A comparative study in Chinese Han patients. MOG-Ab, NMOSD
17  2020 Neuromyelitis optica spectrum disorder: pregnancy-related attack and predictive risk factors. ARR, NMOSD
18  2020 Possible clinical role of MOG antibody testing in children presenting with acute neurological symptoms. ADEM, CNS, MOG-Abs, MS, NMOSD
19  2020 Precision therapy for neuromyelitis optica spectrum disorder: A retrospective analysis of the use of class-switched memory B-cells for individualised rituximab dosing schedules. MOG-Ab, NIC, NMOSD, RTX, SMB-cells
20  2020 Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease. ADEM, MOG-Ab
21  2020 Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review. ---
22  2019 A highly specific and sensitive nanoimmunosensor for the diagnosis of neuromyelitis optica spectrum disorders. NMOSD
23  2019 Aquaporin-4 IgG antibody-related disorders in patients with juvenile systemic lupus erythematosus. ---
24  2019 Different Characteristics of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Seropositive Male Optic Neuritis in China. AQP4-ON, MOG-Ab, MOG-ON, ON
25  2019 Different magnetic resonance imaging features between MOG antibody- and AQP4 antibody-mediated disease: A Chinese cohort study. LETM, MOG-Ab, MRI
26  2019 Neuromyelitis optica spectrum disorder after treatment with pembrolizumab. ICIs, irAEs, NMOSD
27  2019 Neuromyelitis optica testing and treatment: Availability and affordability in 60 countries. MOG-Ab
28  2018 A prospective case-control study comparing optical coherence tomography characteristics in neuromyelitis optica spectrum disorder- optic neuritis and idiopathic optic neuritis. BCVA, CT, IDON, MME, NMOSD-ON, OCT, ON, RNFL, RNFLT, RT
29  2018 Anti-aquaporin-4 Antibody Positive Optic Neuritis Following Scrub Typhus in an Elderly Female. NMOSD, ON
30  2018 Aquaporin-4 Serostatus and Visual Outcomes in Clinically Isolated Acute Optic Neuritis. MSON, NMOSD, ON
31  2018 Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder. CSF, IL, mtDNA, NLRP3, NMOSD, TLR9
32  2018 Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients. AQP4-ON, MOG-Ab, MOG-ON, ON
33  2018 Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. CI, HR, MOG-Ab
34  2018 CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders. AUC, EDSS, GFAP, MOG-Ab, MS, NMOSD, OND
35  2018 Detection of aquaporin-4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania. CNS, MS, NMO
36  2018 Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China. MOG-Abs, NMDARE
37  2018 Hyponatremia in neuromyelitis optica spectrum disorders: Literature review. CSWS, NMOSDs, SIADH
38  2018 Longitudinally extensive transverse myelitis with pulmonary tuberculosis: Two case reports. CSF, EDSS, FLAIR, LETM, MRI, NMOSD, PTB, T1W, T2W
39  2018 Myelin oligodendrocyte glycoprotein antibodies in neurological disease. ADEM, MOG, MS, NMOSD
40  2018 Pediatric Neuromyelitis Optica Spectrum Disorders. NMOSDs
41  2018 Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders. ADC, MRI, MS, NMOSD
42  2018 Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome. Ab-ON, logMAR, MOG-Ab, MS-ON, NMOSD, RDS, RNFL
43  2018 Short-segment transverse myelitis lesions in a cohort of Latin American patients with neuromyelitis optica spectrum disorders. EDSS, LETM, MRI, NMOSD, STM
44  2018 Syringomyelia-like syndrome in neuromyelitis optica spectrum disorder complicated with Sjogren's syndrome: a case report. LSG, NMOSD, pSS
45  2018 The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis. MOG-Ab, ON
46  2018 [Clinical presentations of neuromyelitis optica spectrum disorders with ultra-longitudinally extensive transverse myelitis]. CSF, GCs, NMOSD, uLETM
47  2017 Analysis of brain and spinal cord lesions to occult brain damage in seropositive and seronegative neuromyelitis optica. BLV, LSCL, MRI, NAGM-GMV, NMO
48  2017 Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS. ARR, IFN, IL, NAT, NMOIT, NMOSD
49  2017 Comprehensive analysis of patients with neuromyelitis optica spectrum disorder (NMOSD) combined with chronic hepatitis B (CHB) infection and seropositive for anti-aquaporin-4 antibody. CHB, CSF, HBV, NMOSD, ON
50  2017 Correction: Accuracy of the Fluorescence-Activated Cell Sorting Assay for the Aquaporin-4 Antibody (AQP4-Ab): Comparison with the Commercial AQP4-Ab Assay Kit. ---
51  2017 Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody. AQP4, NMOSD
52  2017 Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity. CNS, LETM, MRI, NMOSD, ON
53  2017 Microstructural visual system changes in AQP4-antibody-seropositive NMOSD. DTI, FT, GCIPL, HCs, LETM, NMOSD-ON, NMOSDs, OCT, ON, OR, pRNFL, VA
54  2017 Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status. MOG-Ab, NfL
55  2016 Accuracy of the Fluorescence-Activated Cell Sorting Assay for the Aquaporin-4 Antibody (AQP4-Ab): Comparison with the Commercial AQP4-Ab Assay Kit. C-CBA, NMO
56  2016 Aquaporin 4 Antibody in the Korean Patient with New-Onset Optic Neuritis. ---
57  2016 Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis. NMOSD
58  2016 Clinical analysis of neuromyelitis optica presenting as intractable nausea, vomiting and hiccups. INH, NMO
59  2016 Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. CSF, MOG, MS, MS, NMOSD
60  2016 False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients. MS, NMOSD, NTZ
61  2016 Influence of female sex and fertile age on neuromyelitis optica spectrum disorders. NMO, NMOSD
62  2016 Occurrence of Asymptomatic Acute Neuromyelitis Optica Spectrum Disorder-Typical Brain Lesions during an Attack of Optic Neuritis or Myelitis. NMOSD, ON
63  2016 Optic neuritis with positive HLA-B27: Characteristic phenotype in the Chinese population. AS, ON
64  2016 Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages. NMO, ON, RNFL, TM
65  2016 Seronegative Neuromyelitis Optica: A Case Report of a Hispanic Male. MRI, NMO
66  2016 Structural Alterations of Segmented Macular Inner Layers in Aquaporin4-Antibody-Positive Optic Neuritis Patients in a Chinese Population. BCVA, GCIP, HC, INL, NMO, OCT, ON, pRNFL
67  2016 [The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica]. CIS, CSF, EDSS, EP, MS, NMO, OB
68  2015 Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications. EDSS, LETM, MS, NMO
69  2015 Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up. ADEM, MS, NMOSD, ON, RION
70  2015 Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease. LETM, NMOSD
71  2015 Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75. NMOSD
72  2015 [Proportion and significance of CD1d(hi)CD5⁺CD19⁺ regulatory B cell in peripheral blood of patients with neuromyelitis optica]. MS, NMO
73  2014 Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. NMO, TCZ
74  2014 Frequency of autoantibodies and connective tissue diseases in Chinese patients with optic neuritis. a-dsDNA, ACA, ANA, beta2GPI, BON, CTDs, ION, ON, RF, RON, SD-OCT, SS
75  2014 Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature. AChR Ab, EOMG, MG, NMOSD, Treg
76  2014 Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability. ARR, EDSS, NMO, NMOSD
77  2014 Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features. NMO, ON, TM
78  2014 Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder. NMO, NMOSD, SSA-Ab
79  2013 Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset. EDSS
80  2013 Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. LETM, NMO
81  2013 Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people. NMO, NMO-SD
82  2013 Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders. MS, NMO, NMOSD
83  2012 Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy. HTLV-1, NMOSD
84  2012 Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis. CSF, ELISA, HC, IFN, IL, NMO, ONDs, RRMS, VLA-4
85  2012 Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: favorable response to cancer treatment. LETM
86  2012 Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. AChR Ab, AChR-MG
87  2012 Preliminary study on the association of AQP4 promoter polymorphism with anti-aquaporin-4 antibody positivity in southern Han Chinese patients with idiopathic demyelinating disorders of central nervous system. AQP4, CMS, NMO, RM, RON
88  2011 Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes. ---
89  2011 Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. NMO
90  2011 Relationship between NMO-antibody and anti-MOG antibody in optic neuritis. MOG, MOG-Ab, MS, NMO-Ab, ON
91  2011 [Antibody-related neuroimmunological disorders: update on the diagnosis and treatment]. NMDAR-Ab, NMO
92  2010 Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. CFA, CNS, NMO
93  2010 HLA-DPB1 0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese. C-MS, CTLs, NMO, SBT
94  2010 [Differential diagnosis of neuromyelitis optica spectrum disorders]. MG, NMO, NMOSD, SjS, SLE
95  2009 Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. CNS, NMO, NMOSD, SS
96  2009 Identification of binding sites for anti-aquaporin 4 antibodies in patients with neuromyelitis optica. ---
97  2009 [Seroprevalence and diagnostic value of aquaporin-4 antibody in patients with inflammatory central nervous system demyelinating diseases]. mLETM, MS, nLETM, NMO, ON, rLETM, TM
98  2008 Anti-aquaporin-4 antibody-positive optic neuritis. ON